BIRD GLOBAL INC-CLASS A (BRDS) Fundamental Analysis & Valuation

NYSE:BRDS • US09077J2069

Current stock price

0.9 USD
-0.01 (-1.52%)
Last:

This BRDS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BRDS Profitability Analysis

1.1 Basic Checks

  • In the past year BRDS has reported negative net income.
  • In the past year BRDS has reported a negative cash flow from operations.
BRDS Yearly Net Income VS EBIT VS OCF VS FCFBRDS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -100M -200M -300M

1.2 Ratios

  • The profitability ratios for BRDS are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BRDS Yearly ROA, ROE, ROICBRDS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -500 -1K

1.3 Margins

  • BRDS has a Gross Margin of 37.01%. This is comparable to the rest of the industry: BRDS outperforms 43.59% of its industry peers.
  • The Profit Margin and Operating Margin are not available for BRDS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BRDS Yearly Profit, Operating, Gross MarginsBRDS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 -50 -100 -150 -200 -250

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. BRDS Health Analysis

2.1 Basic Checks

  • BRDS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BRDS has more shares outstanding
  • BRDS has a worse debt/assets ratio than last year.
BRDS Yearly Shares OutstandingBRDS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 50M 100M 150M 200M 250M
BRDS Yearly Total Debt VS Total AssetsBRDS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

  • BRDS has an Altman-Z score of -12.27. This is a bad value and indicates that BRDS is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -12.27, BRDS is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -12.27
ROIC/WACCN/A
WACC9.84%
BRDS Yearly LT Debt VS Equity VS FCFBRDS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 200M -200M

2.3 Liquidity

  • BRDS has a Current Ratio of 0.21. This is a bad value and indicates that BRDS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.21, BRDS is not doing good in the industry: 87.18% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.19 indicates that BRDS may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.19, BRDS is doing worse than 87.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.19
BRDS Yearly Current Assets VS Current LiabilitesBRDS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. BRDS Growth Analysis

3.1 Past

  • The earnings per share for BRDS have decreased strongly by -441.18% in the last year.
  • The Revenue for BRDS has decreased by -11.19% in the past year. This is quite bad
  • BRDS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.58% yearly.
EPS 1Y (TTM)-441.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-108.57%
Revenue 1Y (TTM)-11.19%
Revenue growth 3Y17.58%
Revenue growth 5YN/A
Sales Q2Q%-52.68%

3.2 Future

  • The Earnings Per Share is expected to decrease by -20.92% on average over the next years. This is quite bad
  • BRDS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.96% yearly.
EPS Next Y-52.06%
EPS Next 2Y-20.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.26%
Revenue Next 2Y9.96%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BRDS Yearly Revenue VS EstimatesBRDS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 100M 200M 300M
BRDS Yearly EPS VS EstimatesBRDS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -10 -20 -30 -40 -50

More info and screens

Find the best growth stocksShow best growing peers

0

4. BRDS Valuation Analysis

4.1 Price/Earnings Ratio

  • BRDS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BRDS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRDS Price Earnings VS Forward Price EarningsBRDS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BRDS Per share dataBRDS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • BRDS's earnings are expected to decrease with -20.92% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.92%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BRDS Dividend Analysis

5.1 Amount

  • BRDS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

BRDS Fundamentals: All Metrics, Ratios and Statistics

BIRD GLOBAL INC-CLASS A

NYSE:BRDS (9/22/2023, 8:04:01 PM)

0.9

-0.01 (-1.52%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)08-09
Earnings (Next)11-13
Inst Owners1.58%
Inst Owner Change0%
Ins Owners426.5%
Ins Owner Change0%
Market Cap11.64M
Revenue(TTM)220.39M
Net Income(TTM)-99.80M
Analysts43.33
Price Target331.5 (36733.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.41%
Min EPS beat(2)-71.57%
Max EPS beat(2)42.75%
EPS beat(4)2
Avg EPS beat(4)2.98%
Min EPS beat(4)-71.57%
Max EPS beat(4)73.64%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-42.7%
Min Revenue beat(2)-54.36%
Max Revenue beat(2)-31.04%
Revenue beat(4)1
Avg Revenue beat(4)-21.17%
Min Revenue beat(4)-54.36%
Max Revenue beat(4)27.95%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)94.03%
PT rev (3m)94.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-2400%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.28
EYN/A
EPS(NY)-6.37
Fwd EYN/A
FCF(TTM)-3.3
FCFYN/A
OCF(TTM)-2.57
OCFYN/A
SpS17.04
BVpS-0.84
TBVpS-3.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.01%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.41%
Cap/Sales 4.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.19
Altman-Z -12.27
F-Score3
WACC9.84%
ROIC/WACCN/A
Cap/Depr(3y)200.34%
Cap/Depr(5y)N/A
Cap/Sales(3y)54.49%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-441.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-108.57%
EPS Next Y-52.06%
EPS Next 2Y-20.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.19%
Revenue growth 3Y17.58%
Revenue growth 5YN/A
Sales Q2Q%-52.68%
Revenue Next Year4.26%
Revenue Next 2Y9.96%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y81.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year112.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.82%
OCF growth 3YN/A
OCF growth 5YN/A

BIRD GLOBAL INC-CLASS A / BRDS Fundamental Analysis FAQ

What is the fundamental rating for BRDS stock?

ChartMill assigns a fundamental rating of 1 / 10 to BRDS.


What is the valuation status for BRDS stock?

ChartMill assigns a valuation rating of 0 / 10 to BIRD GLOBAL INC-CLASS A (BRDS). This can be considered as Overvalued.


How profitable is BIRD GLOBAL INC-CLASS A (BRDS) stock?

BIRD GLOBAL INC-CLASS A (BRDS) has a profitability rating of 0 / 10.


How financially healthy is BIRD GLOBAL INC-CLASS A?

The financial health rating of BIRD GLOBAL INC-CLASS A (BRDS) is 0 / 10.